نتایج جستجو برای: snp309

تعداد نتایج: 201  

Journal: :Genetics and molecular research : GMR 2012
J N Zhang S H Yi X H Zhang X Y Liu Q Mao S Q Li W H Xiong Y M Qiu T Chen J W Ge

Epidemiological studies of the association of variants p53 Arg72Pro and MDM2 single-nucleotide polymorphism 309 (SNP309) with glioma risk have produced inconsistent results. The aim of the current study was to evaluate the association of these 2 variants with glioma susceptibility using a meta-analysis approach. For p53 Arg72Pro, 10 case-control studies including 2587 glioma patients and 40...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2007
Hiroshi Hirata Yuji Hinoda Nobuyuki Kikuno Ken Kawamoto Yutaka Suehiro Yuichiro Tanaka Rajvir Dahiya

PURPOSE MDM2 is a major negative regulator of p53, and a single nucleotide polymorphism in the MDM2 promoter region SNP309 (rs2279744) has been shown to increase the affinity of the transcriptional activator Sp1, resulting in elevated MDM2 transcription and expression in some cancers. There is currently no information about the role of MDM2 polymorphism in renal cell carcinoma (RCC). We investi...

Background: Breast cancer is one of the most common cancers among women worldwide. Tumor protein 53 (TP53) and its regulator the mouse double murine 2 (MDM2) have important roles in tumorigenesis by playing key roles in cell division and response to DNA damage. MDM2 SNP309 T>G (rs2279744) polymorphism in the promoter region of MDM2 gene can cause dysfunction and inactivation of TP53 which promo...

2014
Agnieszka Zając Beata Smolarz Grzegorz Stachowiak Jacek R. Wilczyński

The aim of the study was to determine an association of TP53 codon 72 (Arg72Pro, G>C transversion, rs1042522) and MDM2 SNP309 (T>G change, rs2279744) polymorphisms in endometrial cancer (EC) of postmenopausal women, regarding grading and staging of EC. In the study, endometrial samples from 202 postmenopausal female patients (the study group, n = 152, was women with EC; the control group, n = 5...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2011
Moriko Ito Louise Barys Terence O'Reilly Sophie Young Bella Gorbatcheva John Monahan Sabine Zumstein-Mecker Peter F Choong Ian Dickinson Philip Crowe Christine Hemmings Jayesh Desai David M Thomas Joanna Lisztwan

PURPOSE Reactivation of p53 tumor suppressor activity in diseases such as soft-tissue sarcoma is considered an attractive means of targeted therapy. By systematically assessing alterations affecting the p53 pathway, we aimed to (a) classify sarcoma subtypes, (b) define a potential role in malignancy, and (c) identify potential patient biomarkers in this heterogeneous disease. EXPERIMENTAL DES...

Journal: :Cumhuriyet Medical Journal 2017

2016
Ying Chan Baosheng Zhu Hongguo Jiang Jinman Zhang Ying Luo Wenru Tang

To evaluate the association of the TP53 codon 72 (rs 1042522) alone or in combination with HDM2 SNP309 (rs 2279744) polymorphisms with human infertility and IVF outcome, we collected 1450 infertility women undergoing their first controlled ovarian stimulation for IVF treatment and 250 fertile controls in the case-control study. Frequencies, distribution, interaction of genes, and correlation wi...

2013
Hans Olsson Per Hultman Johan Rosell Peter Söderkvist Staffan Jahnson

BACKGROUND Urinary bladder carcinoma stage T1 is an unpredictable disease that in some cases has a good prognosis with only local or no recurrence, but in others can appear as a more aggressive tumor with progression to more advanced stages. The aim here was to investigate stage T1 tumors regarding MDM2 promoter SNP309 polymorphism, mutations in the p53 gene, and expression of p53 and p16 measu...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید